Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/novartis-files-supreme-court-bid-gilenya-patent-case
https://news.bloomberglaw.com/health-law-and-business/generic-drugmaker-asks-justices-to-lift-pause-on-gilenya-ruling?context=search&index=11
https://www.novartis.com/news/media-releases/novartis-announces-us-court-appeals-federal-circuit-cafc-upholds-validity-gilenya-fingolimod-dosage-regimen-patent
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207939
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207939
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208508
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207939
https://www.fiercepharma.com/pharma/fda-green-lights-3-generics-novartis-ms-star-gilenya-amid-legal-fight-to-keep-them-off
https://seekingalpha.com/news/3522265-lannett-enters-new-insulin-glargine-deal-hec
https://www.biospectrumasia.com/news/30/14893/111-to-establish-healthcare-retail-channel-with-hec.html